Citable filing context
CNC's research view summarizes recent SEC filing context, starting with management_change from Aug 17, 2026.
| Filed | Item | Context |
|---|---|---|
| Aug 17, 2026 | management_change | CFO Andrew Asher announced his retirement; Christopher Neczypor was named successor CFO effective January 1, 2027. |
| Jul 29, 2026 | debt_offering | Centene Corporation announced the partial redemption of $500 million of its 4.25% Notes due 2027. |
| Jul 28, 2026 | earnings | Centene reported Q2 2026 GAAP diluted EPS of $2.19 and increased its full-year 2026 adjusted EPS guidance. |
| Aug 17, 2026 | Guidance: adjusted_diluted_eps | 4.80 to not reported |
| Jul 28, 2026 | Guidance: adjusted_diluted_eps | not reported to not reported |
| Jul 28, 2026 | Guidance: gaap_diluted_eps | not reported to not reported |
| Jul 28, 2026 | mda_quarterly | Centene Corporation’s financial performance for the first half of 2026 reflects a strategic pivot toward profitability, marked by a 149% increase in net earnings compared to the same period in 2025. The company’s Health Benefits Ratio (HBR) improved to 88.4% from 90.2%, driven by disciplined pricing in the Marketplace segment, favorable Medicare Part D risk-sharing resolutions, and effective medical cost management in Medicaid. Total revenues grew 9% to $103.5 billion, despite an 8% decline in total managed care membership to 25.9 million. This membership contraction, particularly in Medicaid and Marketplace, stems from ongoing post-pandemic eligibility redeterminations and corrective pricing actions. Centene is actively navigating regulatory headwinds, including the expiration of enhanced Advance Premium Tax Credits (APTCs) and the implementation of the One Big Beautiful Bill Act (OBBBA), which introduces new work requirements and cost-sharing mandates. Liquidity remains robust, with $8.0 billion in operating cash flow for the first half of 2026. The company continues to execute its capital allocation strategy, repurchasing $1.3 billion in senior notes to reduce leverage. Management is focused on enterprise optimization and the divestiture of remaining Magellan Health businesses, while prioritizing D-SNP integration to capture long-term growth in the dual-eligible market. |
| Apr 28, 2026 | mda_quarterly | Centene Corporation’s first-quarter 2026 financial results reflect a 7% year-over-year revenue increase to $49.9 billion, driven by premium yield growth in Medicare Part D and Medicaid rate adjustments. The company reported a health benefits ratio (HBR) of 87.3%, an improvement from 87.5% in the prior-year period, aided by disciplined medical cost management and the absence of 2026 Medicare Advantage premium deficiency reserves. Membership trends remain a primary focus, with total managed care membership declining 6% to 26.3 million. This contraction is largely attributed to ongoing Medicaid eligibility redeterminations and a significant reduction in Marketplace membership following the expiration of enhanced Advance Premium Tax Credits and the implementation of the Marketplace Integrity and Affordability Final Rule. Centene responded with corrective pricing actions on 95% of its Marketplace business for 2026. Liquidity remains robust, with $4.4 billion in operating cash flow. The company actively managed its capital structure by repurchasing $1.0 billion of senior notes and utilizing a new receivable purchase agreement to monetize $1.0 billion of 2025 Part D risk-sharing receivables. Key risks include ongoing regulatory uncertainty, potential Medicaid bid protests in Georgia and Texas, and the evolving morbidity profile of the Marketplace population. |
Source: SEC EDGAR filing text and events; period Aug 17, 2026; filed Aug 17, 2026.
CNC company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.